ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,919,222 | -67.8% | 385,472 | -63.6% | 0.16% | -65.1% |
Q2 2023 | $21,518,039 | +121.6% | 1,059,480 | +99.0% | 0.47% | +137.7% |
Q1 2023 | $9,710,629 | +457.4% | 532,381 | +532.0% | 0.20% | +397.5% |
Q4 2022 | $1,742,166 | -68.0% | 84,244 | -51.1% | 0.04% | -68.3% |
Q1 2022 | $5,438,000 | +339.3% | 172,300 | +463.1% | 0.13% | +334.5% |
Q4 2021 | $1,238,000 | +57.1% | 30,600 | +6.6% | 0.03% | +16.0% |
Q2 2021 | $788,000 | – | 28,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |